Recursion Pharmaceuticals (RXRX) Net Cash Flow Growth (5y) (2025 - 2026)

Recursion Pharmaceuticals (RXRX) Net Cash Flow Growth (5y) (2025 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	66,561.01 Bn	66,560.72 Bn	-
2	Nanobiotix	1,912.79 Bn	1,912.72 Bn	-
3	Akari Therapeutics	1,045.06 Bn	1,045.06 Bn	-
4	BeOne Medicines	469.79 Bn	465.00 Bn	1.35 Bn
5	Vertex Pharmaceuticals	122.95 Bn	115.70 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	70.05 Bn	61.30 Bn	3.31 Bn
7	Belite Bio	62.62 Bn	62.62 Bn	-
8	Argenx Se	56.18 Bn	50.99 Bn	1.41 Bn
9	Revolution Medicines	37.35 Bn	37.35 Bn	-
10	Recursion Pharmaceuticals	1.61 Bn	949.05 Mn	-6.02 Mn

Download Data